Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$0.00
$4.35
▼
$11.97
$1.01B4.52528,025 shs1.43 million shs
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
$0.26
$0.34
$0.25
▼
$0.72
$277.90M0.371.18 million shs2.03 million shs
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$26.35
$25.45
$18.80
▼
$27.66
$1.05B0.26548,733 shs470,090 shs
Vectura Group plc stock logo
VEGPF
Vectura Group
$1.77
$1.77
$1.64
▼
$2.74
$1.07B0.372,185 shsN/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00%0.00%0.00%0.00%0.00%
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
0.00%-10.70%-28.53%-30.29%-63.14%
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
0.00%+2.29%+5.32%+15.27%-0.38%
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$0.00
$4.35
▼
$11.97
$1.01B4.52528,025 shs1.43 million shs
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
$0.26
$0.34
$0.25
▼
$0.72
$277.90M0.371.18 million shs2.03 million shs
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$26.35
$25.45
$18.80
▼
$27.66
$1.05B0.26548,733 shs470,090 shs
Vectura Group plc stock logo
VEGPF
Vectura Group
$1.77
$1.77
$1.64
▼
$2.74
$1.07B0.372,185 shsN/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00%0.00%0.00%0.00%0.00%
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
0.00%-10.70%-28.53%-30.29%-63.14%
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
0.00%+2.29%+5.32%+15.27%-0.38%
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00
N/AN/AN/A
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
0.00
N/AN/AN/A
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
2.43
Hold$30.2014.61% Upside
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ELTP, VEGPF, PCRX, and CNTTF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D+) ➝ Hold (C-)
8/17/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
8/17/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$30.00
8/5/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$24.00 ➝ $25.00
8/5/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$32.00 ➝ $33.00
7/1/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$38.00
(Data available from 9/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$15.96M0.00N/AN/AN/ANaN
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
$148.87M1.87$0.03 per share9.66$0.09 per share2.87
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$726.41M1.45$3.86 per share6.83$16.11 per share1.64
Vectura Group plc stock logo
VEGPF
Vectura Group
$244.76M4.37$0.28 per share6.33$1.16 per share1.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A$0.07137.18N/AN/AN/AN/AN/AN/A
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
$44.87M$0.046.45N/AN/A40.19%44.58%29.54%11/12/2026 (Estimated)
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$7.03M$0.3575.2910.98N/A1.96%9.68%5.30%11/5/2026 (Estimated)
Vectura Group plc stock logo
VEGPF
Vectura Group
$157.16M$0.266.8117.70N/AN/AN/AN/AN/A

Latest ELTP, VEGPF, PCRX, and CNTTF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q1 2027
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
N/A$0.01N/A$0.01N/AN/A
8/4/2026Q2 2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$0.6460$0.73+$0.0840$0.12$191.06 million$192.40 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/AN/AN/A
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
N/AN/AN/AN/AN/A
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
N/AN/AN/AN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/A
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
0.03
3.76
2.97
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
0.54
5.04
3.94
Vectura Group plc stock logo
VEGPF
Vectura Group
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.08%
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
0.01%
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
99.73%
Vectura Group plc stock logo
VEGPF
Vectura Group
N/A

Insider Ownership

CompanyInsider Ownership
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
14.42%
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
6.40%
Vectura Group plc stock logo
VEGPF
Vectura Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A105.61 millionN/ANot Optionable
Elite Pharmaceuticals Inc. stock logo
ELTP
Elite Pharmaceuticals
401.08 billion921.81 millionNot Optionable
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
72039.86 million37.31 millionOptionable
Vectura Group plc stock logo
VEGPF
Vectura Group
502604.26 millionN/ANot Optionable

Recent News About These Companies

Philip Morris closes on the sale of Vectura Group
January 2, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/philip-morris-closes-on-the-sale-of-vectura-group/ar-AA1wQN6L
M&A News: Philip Morris (NYSE:PM) Will Sell Vectura for $198M
September 17, 2024  |  msn.comhttps://www.msn.com/en-us/money/topstocks/m-a-news-philip-morris-nyse-pm-will-sell-vectura-for-198m/ar-AA1qJ9cR
Vectura and Hikma to develop US asthma generic
August 20, 2024  |  pharmaphorum.comP
European Stocks See Mixed Session as U.K.'s FTSE Leads
January 16, 2023  |  thestreet.comhttps://www.thestreet.com/markets/european-stocks-see-mixed-session-as-u-k-s-ftse-leads-14129201
VECTURA GROUP LS -,000271 (V4TA.BE)
January 15, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/quote/V4TA.BE/history/
Vectura Group PLC (V4TA.BE)
January 9, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/quote/V4TA.BE/history?p=V4TA.BE
Results for 'Vectura-Fertin Pharma'
October 11, 2022  |  afaqs.comA
Vectura Group (OTC:VEGPF), Short Interest Report
July 18, 2022  |  benzinga.comhttps://www.benzinga.com/quote/VEGPF/short-interest
Carlyle stays in race for Vectura
August 27, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/carlyle-stays-race-vectura-145301112.html?.tsrc=rss
Form 8.3 - Form-8.3 - VECTURA GROUP PLC - 20210826
August 27, 2021  |  finance.yahoo.comhttps://finance.yahoo.com/news/form-8-3-form-8-093300735.html?.tsrc=rss
Philip Morris chief attacks critics as Vectura bid tests investors
August 20, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/philip-morris-chief-attacks-critics-164642627.html?.tsrc=rss
Markets: FTSE inches to new post-pandemic high as Vectura takeover draws closer
August 13, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/stock-market-13-august-ftse-cac-dax-sp500-dow-jones-nasdaq-vectura-philip-morris-takeover-marlboro-disney-adidas-075223887.html?.tsrc=rss
Vectura auction called off after Carlyle declines to beat Philip Morris bid
August 10, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/vectura-auction-called-off-carlyle-172600705.html?.tsrc=rss
UPDATE 1-Vectura takeover battle could slip into auction - UK regulator
August 9, 2021  |  finance.yahoo.comhttps://finance.yahoo.com/news/1-vectura-takeover-battle-could-091519978.html?.tsrc=rss
Philip Morris, Carlyle could fight it out for UK's Vectura in auction ring
August 9, 2021  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/news/philip-morris-carlyle-could-fight-091841300.html?.tsrc=rss

New MarketBeat Followers Over Time

Media Sentiment Over Time

CannTrust stock logo

CannTrust OTCMKTS:CNTTF

CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.

Elite Pharmaceuticals stock logo

Elite Pharmaceuticals OTCMKTS:ELTP

$0.26 0.00 (0.00%)
As of 09/4/2026 03:55 PM Eastern

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals. It owns, licenses, manufactures, and sells various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets under the Adderall brand, as well as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release capsules under the Adderall XR brand for central nervous system diseases; Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the Loxapine brand; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, attention deficit, and infection. Further, the company is developing a range of abuse deterrent opioid products. Elite Pharmaceuticals, Inc. was incorporated in 1997 and is headquartered in Northvale, New Jersey.

Pacira BioSciences stock logo

Pacira BioSciences NASDAQ:PCRX

$26.35 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Vectura Group stock logo

Vectura Group OTCMKTS:VEGPF

$1.77 0.00 (0.00%)
As of 11/1/2021

Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas